Skip to content
Sign in

Prostate MRI report says PI-RADS 3 lesion. Doctor is talking about biopsy or repeat MRI. What does PI-RADS 3 mean?

An AskHim answer: what is known, what depends on you, and what only a clinician can decide.

From AskHim’s editorial team. The team wrote this question to open the topic. It is not anyone’s submission, and nobody’s own words are in it.

Editorially reviewed Version 1 · Last reviewed 11 November 2026 · English

The short explanation

PI-RADS is a scoring system radiologists use to describe areas seen on a prostate MRI, from 1 to 5. A score of 1 or 2 means clinically important cancer is unlikely; 4 or 5 means it is likely. A score of 3 is the uncertain middle: the area looks a little unusual, but it could be inflammation, benign enlargement or a small cancer. Because PI-RADS 3 is uncertain, doctors look at other information to decide the next step. This often includes your PSA level, how fast it has been rising, PSA density, which is PSA compared with prostate size, your family history and your preferences. Some men are advised to have a targeted biopsy; others repeat PSA and MRI after some months.

What depends on your situation

The parts of this that change from person to person. Uncertainty is stated, not hidden.

  • Most PI-RADS 3 areas do not turn out to be significant cancer, but some do, which is why a plan for follow-up matters. Ask for the full MRI report and keep copies.
  • Biopsy techniques differ. Some centres take samples through the skin between the scrotum and anus, which carries a lower infection risk; others go through the back passage. Ask which method will be used.

What this answer cannot determine

The boundary of online education. These need a clinician who can see you.

  • This cannot tell whether the area on your MRI is cancer. That needs your urologist's assessment and possibly a biopsy.

Questions for your clinician

Take these with you. You can add any of them to an appointment card.

  1. What is my PSA density?
  2. Do you recommend a biopsy now or a repeat MRI later?
  3. If biopsy, which method and what are the risks?
  4. When should the next PSA be done?

When to seek help

Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.

Emergency — call 112 now

  • Call 112 or 108 if you develop fever with shivering after a biopsy or cannot pass urine.

Raise it at a routine appointment

  • Discuss the MRI result and plan at your urology follow-up.

Sources

The evidence this explanation is built on.

  1. Prostate cancer National Cancer Institute (NIH)
  2. Prostate cancer NHS
  3. Prostate cancer MedlinePlus (US National Library of Medicine)

Who wrote and reviewed this

Every AskHim answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.

Author
AskHim Editorial (AI-assisted)
Clinical reviewer
Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHim’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
Review status
Editorially reviewed
Last reviewed
Last reviewed 11 November 2026
Version
1

Correction history

Substantive changes are listed, not quietly edited away.

No corrections have been made since this answer was first published.

Did this answer your question?

Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.

Explain more simply

“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.


Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.